TLPH
TLPH
NASDAQ · Pharmaceuticals

Talphera Inc

$1.01
-0.04 (-3.81%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +2,487.1% upside
Low Target $16.33
Average Target $26.13
High Target $37.99
Current Price $1.01
Current
$1.01
Target
$26.13
$16.33 $26.13 avg $37.99
Scenario Analysis
Bear Case
$16.33
1,516.8%
Low target
Base Case
$26.13
+2,487.1%
Avg target
Bull Case
$37.99
+3,661.4%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$1.57
-35.7% from high
52-Week Low
$0.69
+47.1% from low
Target vs 52W High
$26.13
+1,564.3% vs high
Next Earnings Report
Nov 16, 2026
9d
until earnings
EPS Est: $-0.06
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%